Bio-Reference Laboratories Announces Collaboration Agreement with Sysmex America to Further Advance Hematology Diagnostics

Bio-Reference Laboratories, Inc. (BRLI – NASDAQ), the largest independent regional clinical laboratory in the Northeast, and Sysmex America, Inc., leading diagnostic instrument manufacturer and information systems developer, today announced that they have signed a letter of intent for the purpose of developing the advanced capabilities found on Sysmex hematology systems into new, clinically important parameters for diagnostic and other purposes.

Please to read the entire article.

You must be logged in to post a comment Login